What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2024-11-13 compared with 2024-08-19 · 43 added, 24 removed, 16 unchanged (81% of the section changed)

OTHER INFORMATION

the fiscal quarter ended June 30, 2024, none of our directors or officers informed us of the adoption , modification or termination of

a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation

S-K, Item 408.

10b5-1 Trading Plans

the quarter ended September 30, 2024, the officers and directors listed below adopted , modified , or terminated trading plans intended

to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

23, 2024 , Scott R.

Henry , a member of our board of directors , entered into a trading plan that provides for the sale of

an aggregate of up to 21,000 shares of our common stock.

The plan will terminate on September 20, 2025 , subject to early

termination for certain specified events set forth in the plan.

24, 2024 , Adam R.

Levy , our Chief Executive Officer and a member of our board of directors, entered into a trading plan that

provides for the sale of an aggregate of up to 32,000 shares of our common stock.

The plan will terminate on September

24, 2025 , subject to early termination for certain specified events set forth in the plan.

“Index to Exhibits” for a description of our exhibits.

Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.1 to Form S-1, filed with the SEC on January 9, 2019).

Certificate of Amendment to Certificate of Incorporation of AquaMed Technologies, Inc.

of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.1 to Form S-1, filed with the SEC on January

Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc.

of Amendment to Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.2 to Form S-1,

filed with the SEC on January 9, 2019).

and Restated Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.3 to Amendment No.

1 to Form S-1, filed with the SEC on March 11, 2019).

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on November 14, 2019)

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on May 29, 2020)

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on August 2, 2021)

Amended and Restated Bylaws of AquaMed Technologies, Inc.

of Amendment to the Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to

Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on November 14, 2019)

of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc.

(incorporated by reference to Exhibit 3.1 to

the Current Report on Form 8-K, filed with the SEC on May 29, 2020)

of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc.

(incorporated by reference to Exhibit 3.1 to

the Current Report on Form 8-K, filed with the SEC on August 2, 2021)

and Restated Bylaws of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.5 to Amendment No.

1 to Form S-1, filed with the SEC on March 11, 2019).

Certification of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

Certification of Chief Executive Officer Pursuant to Section 18 U.S.C.

Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Certification of Chief Financial Officer Pursuant to Section 18 U.S.C.

Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

following materials from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter June 30, 2024, formatted in iXBRL

(Inline eXtensible Business Reporting Language), (i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Stockholders’

1 to Form S-1, filed

with the SEC on March 11, 2019).

Certification

of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

Certification

of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

Certification

of Chief Executive Officer Pursuant to Section 18 U.S.C.

Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act

Certification

of Chief Financial Officer Pursuant to Section 18 U.S.C.

Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act

following materials from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter September 30, 2024, formatted in

iXBRL (Inline eXtensible Business Reporting Language), (i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Stockholders’

Equity, (iv) Statements of Cash Flows, and (v) Notes to the Financial Statements.

4 unchanged sentences

the undersigned thereunto duly authorized.

August 19, 2024

November 13, 2024

Executive Officer

3 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information